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Abstract
Objective: To study the relevance of high-sensitive troponin measurements in the acute workup in patients admitted to the
emergency department of a large university hospital due to syncope.
Methods: In this retrospective study all patients admitted to the emergency department because of syncope of the
Inselspital, University Hospital Bern between 01 August 2010 and 31 October 2012, with serial determination of high-
sensitive troponin (baseline and three hours control) were included. Of all identified patients we obtained data on
demographics, laboratory data, ECG as well as on outcome. A change in high-sensitive troponin in the three hours control of
+/230% compared to baseline was considered significant.
Results: A total of 121 patients with a mean age of 67 years (SD 16) were included in the study. 79 patients (65%) were male
and 42 (35%) were female. There was no significant difference in the median high sensitive-troponin level at baseline and in
the three hours control (0.01 mcg/L [0.003 to 0.022] versus 0.011 mcg/L [0.003 to 0.022], p = 0.47). Median percent change
in high-sensitive troponin level between baseline and control was 0% (29.1 to 5). 51 patients (42%) had elevated high-
sensitive troponin levels at baseline with 7 patients (6%) showing a dynamic of +/230% change from the baseline
measurement in the 3 hours control. 3 of these patients received coronary angiography due to the dynamic in high-
sensitive troponin, none of whom needed intervention for coronary revascularization.
Conclusions: On basis of the current study, where no single patient took benefit from determination of high-sensitive
troponin, measurement of cardiac troponins should be reserved for patients with syncope presenting with symptoms
suggestive for the presence of an acute cardiac syndrome.
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Introduction
In the Guidelines of the European Society of Cardiology,
syncope is defined as a transient loss of consciousness caused by a
self-limiting global cerebral hypoperfusion characterized by rapid
onset, short duration, and spontaneous complete recovery [1].
About 1 to 3% of admissions to the emergency department (ED)
and 6% of hospital admissions are due to syncope [2]. While many
cases of syncope have a benign cause, syncope under certain
circumstances is an alarming sign for serious underlying pathol-
ogies such as severe aortic stenosis or cardiac arrhythmias [3].
Cardiac syncope is associated with the worst prognosis with a 1-
year mortality of 10–30% while vasovagal or situation syncope is
not associated with an increased mortality [4,5]. Current
guidelines on the evaluation for syncope exist from the large
cardiologic societies and are freely available online. Although
neither the guidelines of the American Heart Association nor those
of the European Society of Cardiology recommend tests for high-
sensitive troponin in patients presenting with syncope, cardiac
troponins are often determined in these patients in daily clinical
practice, despite syncope is not regarded a classic symptom of
acute coronary syndrome. Thus, we hypothesized that serial
determination of high-sensitive troponin to detect unstable
coronary artery disease as an underlying cause of syncope does
not result in a benefit in the workup of patients presenting to an
ED due to syncope.
So far only one clinical study has determined the role of high-
sensitive troponin in the evaluation of syncope [6]. Surprisingly,
the authors found that the majority (77%) of the 338 included
patients had troponin levels above the limit of detection. 36% of
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patients had a high-sensitive troponin level above the 99th
percentile of the reference population. However, the study did
not answer the question in which way a determination of troponin
is of any benefit for the patient in the workup of syncope.
In the present study we aimed to determine the relevance of
serial high-sensitive troponin determination in patients presenting
to a large emergency department of a university hospital.
Additionally, we wanted to identify the number of patients with
acute myocardial infarction detected by serial high-sensitive
troponin measurements in patients admitted to an ED for syncope.
Methods
Ethics Statement
The study was approved by our local institutional review board
(Ethics Comission of the Canton of Bern, Switzerland – www.kek-
bern.ch). The need for written consent was waived by our
institutional review board due to the retrospective design of the
study.
In this retrospective study, we screened the database of the
Department of Emergency Medicine of the Inselspital, University
Hospital Bern, a large university hospital, in order to identify all
patients presenting with syncope. Of all patients presenting with
syncope, those with serial measurements of high-sensitive troponin
as determined during the stay in our ED between 01 August 2010
and 31 October 2012 were included.
High-sensitive troponin was measured by the Center for
Laboratory Medicine using the Roche Modular E170, an
electrochemiluminescence immunoassay. The reference range of
high-sensitive troponin in our laboratory is defined as
,0.014 mcg/L, equivalent to the 99th percentile of high-sensitive
troponin in the normal population. The limit of detection of high-
sensitive troponin in our laboratory equals 0.003 mcg/L.
Of all identified patients we gathered demographic data
including age and sex as well as data on the admission cause,
cardiovascular risk factors including known coronary arteries
disease, diabetes, arterial hypertension, dyslipidemia, history of
smoking, cardiovascular family history and adipositas. Addition-
ally, we obtained information on the medication presently taken
by the patients, ECG and laboratory data (high-sensitive troponin
levels, electrolytes, c-reactive protein and creatinine levels. Data on
outcome including hospitalization rate, hospital length of stay and
in hospital mortality were registered in the database.
On basis of serial high-sensitive troponin measurements we
calculated percent changes between the second and the first
determination. A rise or fall exceeding or equaling 30% of the
baseline high-sensitive troponin measurement was considered
significant [7].
Results are presented as means and standard deviation (SD) or
median and first and third quartile, as appropriate. Wilcoxon
matched pairs test was used to compare serial high troponin
measurements. A p-value ,0.05 was considered to be significant.
Results
During the study period a total of 55.422 patients were admitted
to the ED. Of these, 1.218 were admitted for syncope. 121 patients
had serial measurements of high-sensitive troponin and were
included in the study. Mean age of patients was 67 years (SD 16).
79 patients (65%) were male and 42 (35%) were female. 4 patients
(3%) presented with minor head trauma along with the syncope.
8 patients (6%) complained of chest pain on admission to the
ED. 41 patients (34%) had abnormalities in the ECG: 19 patients
(46%) showed ST segment depression, 8 (20%) right bundle
branch block, 5 (12%) a negative T wave, 3 (7%) a left bundle
branch block, 2 (5%) presence of Q-waves and bifascicular block,
respectively. Tachycardic atrial fibrillation and atrioventricular
block grade I was present in 1 patient (2%), respectively. All
patients received a baseline measurement of high-sensitive
troponin in the ED and a control measurement three hours after
ED admission. Median high sensitive-troponin level at baseline
was 0.01 mcg/L (0.003 to 0.022) and three hours control was
0.011 mcg/L (0.003 to 0.022). Table 1 gives an overview on the
high-sensitive troponin distribution at baseline and the three hours
dynamic. There was no difference between the baseline measure-
ment and the three hours control (0.01 vs 0.011 mcg/L, p = 0.47).
Median change in high-sensitive troponin level between baseline
and 3 hours control measurement was 0 mcg/L (20.001 to 0.001;
Figure 1). Median percent change in high-sensitive troponin level
between baseline and control was 0% (29.1 to 5).
70 patients (58%) had a high-sensitive troponin measurement of
,0.014 mcg/L at baseline, while 4 of them had increases to a
level equaling or exceeding the cutoff for the normal range of
0.014 mcg/L at the control measurement. However, only in one
of these patients a significant troponin rise exceeding 30% of the
baseline value was found (790% rise or from 0.01 to 0.89 mcg/L).
The patient was found to suffer from intracranial bleeding, finally
ending lethal.
51 patients (42%) had elevated high-sensitive troponin levels at
baseline with 7 patients (6%; only one presenting with chest pain)
showing a dynamic of +/230% change from the baseline
measurement in the 3 hours control. In 3 of the patients with a
high-sensitive troponin dynamic exceeding 30% from baseline to
control no none-cardiac cause could be attributed to the rise in
troponin and they finally received coronary angiography. How-
ever, none of the patients was found to have a significant stenosis
in the coronary angiography leaving the cause for the elevated
troponin unclear. None of the 7 patients with a high-sensitive
troponin change of +/230% from baseline measurement died.
No single patient included in our study finally received the
diagnosis of acute coronary syndrome. One patient (1%) died
during hospitalization from intracerebral hemorrhage.
Discussion
In the present study, we found that 121 patients received
measurement of high-sensitive troponin during their initial
evaluation at the ED for syncope. Although 42% of patients
showed initial high-sensitive troponin levels of $0.014 mcg/L,
only 6% had a significant high-sensitive troponin dynamic of +/
230% at the 3 hours control measurement. 3 of the patients
received coronary angiography, all of which ended without need
for intervention.
Although troponin measurements are not recommended in the
current guidelines for the evaluation of syncope of the large
societies, it is often performed by physicians in daily clinical
practice [1,3,8]. Reed an coworkers studied high-sensitive
troponin measurement in 338 patients admitted to an ED for
syncope [6]. High-sensitive troponin was measured 12 hours after
the syncope. The authors found that patients with elevated high-
sensitive troponin results had a significantly increased probability
of reaching the endpoint of a serious outcome including death [6].
Sun and colleagues in a similar study found that an elevated
conventional troponin I was associated with adverse 30-day
outcome in patients of 60 years or older after presentation for
syncope to an ED [8]. However, both studies left open the
question on how this information does alter management of
patients presenting with syncope. The present study showed that
High-Sensitive Troponin in Syncope
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determination of high-sensitive troponin levels in patients
presenting with syncope to an ED did (as could be expected) not
result in detection of unstable coronary artery disease as the cause
of syncope. We do not have data on long term outcome of
patients, but it should be noted that it was not our intention to
(repeatedly) show that high-sensitive troponin elevation is associ-
ated with adverse outcome, but to analyze whether its determi-
nation is of any benefit for the patient in the acute workup for
syncope.
It is well described today that various patient populations with
an elevation of high-sensitive troponin are at risk for adverse
outcome [9–11]. However, the use of high-sensitive troponin
measurement in the evaluation of syncope is not clear so far. In
our population no single patient was diagnosed with acute
coronary syndrome in the ED. Three patients in our cohort
received coronary angiography due to a dynamic in serial high-
sensitive troponin measurements. However, none of the patients
needed an intervention for revascularization. On basis of the
current data a measurement of high-sensitive troponin cannot be
recommended in the routine evaluation of patients admitted to the
ED for syncope. Results of the high-sensitive troponin measure-
ment might be elevated for several reasons: Hypertensive crisis,
heart failure, pulmonary embolism, renal insufficiency, blunt chest
trauma, aortic dissection or even strenuous exercise can lead to
elevated high-sensitive troponin levels [12]. Receiving such
elevated high-sensitive troponin levels will then bring the physician
into a dilemma of how to proceed often ending in serial
measurements without trend-setting results.
But there is also a financial aspect: Currently one determination
of high-sensitive troponin in our institution costs the amount of 23
Swiss Francs (approximately 24 United States Dollar). The routine
determination of high-sensitive troponin in a common (and often
benign) condition such as syncope would result in serious amounts
of unnecessary health care spending.
Our study is limited by its retrospective and single site design.
The detailed thoughts behind ordering high-sensitive troponin
Figure 1. Box-plots of serial high-sensitive troponin measurements in mcg/L. While hs-troponin 1 is the baseline determination and hs-
troponin 2 is the 3 hours control.
doi:10.1371/journal.pone.0066470.g001
Table 1. Overview of high-sensitive troponin distribution and dynamic at the three hours control.
Baseline high-sensitive troponin Number (%)
Rise to $0.014 mcg/L in 3 hours
control, number (%)
Change in high-sensitive troponin at
3 hours control of 630%
,0.003 mcg/L 37 (31%) 0 (0%) 5 (14%)
0.003–0.013 mcg/L 33 (27%) 4 (12%) 8 (24%)
$0.014 mcg/L 51 (42%) 2 7 (14%)
doi:10.1371/journal.pone.0066470.t001
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determination of the physician in charge are unknown. Addition-
ally, we do not have information on long-term outcome of
patients. On the other hand, long term outcome is not necessary in
order to answer our study question.
In conclusion, based on our study in which no single patient
took benefit from the determination of high-sensitive troponin,
routine measurements of cardiac troponins cannot be recom-
mended for the evaluation of syncope in the ED. In the workup for
syncope, the measurement should be reserved for patients who
present with symptoms suggestive for the presence of acute
coronary syndrome.
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